SEO URLwww.firestrike.ai/deals/biocare-medical-agilent-technologies-acquisition-2026-1

acquisitionAnnounced · Mar 9, 2026Clinical PathologySource · CredibleArticle · Factual

Biocare Medical · Agilent Technologies

Agilent Technologies acquires Biocare Medical

David Najork · Founding Software Engineer

Published Apr 29, 2026 · Updated Apr 29, 2026 · 1 min read

ShareX LinkedIn Email

Deal value

$950M

Target

Biocare Medical

Pacheco, California

Acquirer

Agilent Technologies

Full Acquisition

Status

Pending

Agilent Technologies agreed to acquire Biocare Medical. Reported deal value: $950M. Status: Pending. Sector: Clinical Pathology. Target headquarters context: Pacheco, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-09. Figures and status may change as filings and press coverage update.

Agilent Technologies Inc has entered into a definitive agreement to acquire Biocare Medical , a global clinical pathology company, from an investor group led by Excellere Partners and GHO Capital Partners LLP, in an all-cash transaction valued at $ 950 million

Deal timeline

Announced

Mar 9, 2026 · clpmag.com

Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.

Sector context

This transaction is classified in Clinical Pathology with a reported deal value of $950M. Figures and status may change as sources update.

Sources: clpmag.com · Primary article · FireStrike proprietary index